BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9772054)

  • 1. Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration.
    Stack WA; Knifton A; Thirlwell D; Cockayne A; Jenkins D; Hawkey CJ; Atherton JC
    Am J Gastroenterol; 1998 Oct; 93(10):1909-13. PubMed ID: 9772054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of metronidazole resistance on bacterial eradication of Helicobacter pylori in infected children.
    Raymond J; Kalach N; Bergeret M; Benhamou PH; Barbet JP; Gendrel D; Dupont C
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1334-5. PubMed ID: 9624470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amoxicillin, gemifloxacin and rabeprazole, as first-line Helicobacter pylori therapy in clinical practice: A pilot study.
    Kilic G; Kilic GE; Özkahraman A; Konur S; Dertli R; Kayar Y
    Medicine (Baltimore); 2024 May; 103(18):e38012. PubMed ID: 38701320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Effect of Clarithromycin Combined with Tinidazole on Helicobacter pylori-Related Gastritis and Its Influence on COX-2 Expression.
    He C; Kong F; Zhu X; Kong F; Zhao W; Liu Y; Wang K
    Biomed Res Int; 2021; 2021():4171019. PubMed ID: 34888378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat.
    Suzuki H; Mori H
    J Gastroenterol; 2018 Mar; 53(3):354-361. PubMed ID: 29138921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eradication of Helicobacter pylori Infection.
    Marcus EA; Sachs G; Scott DR
    Curr Gastroenterol Rep; 2016 Jul; 18(7):33. PubMed ID: 27177639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of Hou Gu Mi Xi for peptic ulcer diseases: Study protocol for a randomized controlled trial.
    Chen X; Yan D; Fang J; Liu W; Nie H; Lv N; Fang N; Gong J; Yu J; Jiang Y; Liu Z; Gan H; Fu Y; Yang D; Xiong Y; Liu D; Chen M; Wang Y; Wang Y; Sun X; Zhou X; Zhu W
    Medicine (Baltimore); 2019 Jul; 98(29):e16561. PubMed ID: 31335741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical perspectives in peptic ulcer disease and gastritis.
    Lipof T; Shapiro D; Kozol RA
    World J Gastroenterol; 2006 May; 12(20):3248-52. PubMed ID: 16718847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of antibiotic resistance patterns in
    Spiteri JA; Zahra G; Schembri J; Pisani A; Borg E; Spiteri N; Bianco EZ; Caruana P; Gauci J; Muscat M; Barbara C; Ellul P
    Ann Gastroenterol; 2021; 34(4):501-509. PubMed ID: 34276188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori infection and long term proton pump inhibitor therapy.
    McColl KE
    Gut; 2004 Jan; 53(1):5-7. PubMed ID: 14684566
    [No Abstract]   [Full Text] [Related]  

  • 11. New Diagnostic Strategies for Detection of Helicobacter pylori Infection in Pediatric Patients.
    Gold BD; Gilger MA; Czinn SJ
    Gastroenterol Hepatol (N Y); 2014 Dec; 10(12 Suppl 7):1-19. PubMed ID: 26491414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Rationale for Confirmation Testing After Treatment of Helicobacter pylori Infection: Implications of Rising Antibiotic Resistance.
    Howden CW; Chey WD; Vakil NB
    Gastroenterol Hepatol (N Y); 2014 Jul; 10(7 Suppl 3):1-19. PubMed ID: 25892981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence Lifetime Imaging Microscopy of Porphyrins in
    Battisti A; Morici P; Sgarbossa A
    Pharmaceutics; 2021 Oct; 13(10):. PubMed ID: 34683966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change in Diagnosis of
    Spagnuolo R; Scarlata GGM; Paravati MR; Abenavoli L; Luzza F
    Antibiotics (Basel); 2024 Apr; 13(4):. PubMed ID: 38667033
    [No Abstract]   [Full Text] [Related]  

  • 15. Vitamin C: A Preventative, Therapeutic Agent Against Helicobacter pylori.
    Hussain A; Tabrez E; Peela J; Honnavar P; Tabrez SSM
    Cureus; 2018 Jul; 10(7):e3062. PubMed ID: 30280058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retracted: Clinical Effect of Clarithromycin Combined with Tinidazole on Helicobacter pylori-Related Gastritis and Its Influence on COX-2 Expression.
    International BR
    Biomed Res Int; 2024; 2024():9783981. PubMed ID: 38550195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of combining antibiotics on resistance: A systematic review and meta-analysis.
    Siedentop B; Kachalov VN; Witzany C; Egger M; Kouyos RD; Bonhoeffer S
    medRxiv; 2023 Oct; ():. PubMed ID: 37503165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clarithromycin Versus Metronidazole in First-Line
    Murata M; Sugimoto M; Mizuno H; Kanno T; Satoh K
    J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32079208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acid peptic diseases: pharmacological approach to treatment.
    Mejia A; Kraft WK
    Expert Rev Clin Pharmacol; 2009 May; 2(3):295-314. PubMed ID: 21822447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness analysis of population-based serology screening and (13)C-Urea breath test for Helicobacter pylori to prevent gastric cancer: a markov model.
    Xie F; Luo N; Lee HP
    World J Gastroenterol; 2008 May; 14(19):3021-7. PubMed ID: 18494053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.